Multiple Sclerosis Incidence Associated with the Soil Lead and Arsenic Concentrations in Taiwan

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Tsai, Ching Piao ^a   Lee, Charles Tzu Chi ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; LEAD;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; ENVIRONMENTAL EXPOSURE; FEMALE; HEAVY METAL POISONING; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRESCHOOL CHILD; SCHOOL CHILD; SEX DIFFERENCE; SOIL ANALYSIS; SOIL POLLUTION; TAIWAN;

ARSENIC; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; INCIDENCE; LEAD; MALE; MULTIPLE SCLEROSIS; NATIONAL HEALTH PROGRAMS; SMOKING; SOIL POLLUTANTS; SUNLIGHT; TAIWAN;

EID: 84879177943     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065911     Document Type: Article

References (24)

1. Elhami SR, Mohammad K, Sahraian MA, Eftekhar H, (2011) A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study. Neuroepidemiology 36: 141-147.
2. Benito-Leon J, (2011) Are the prevalence and incidence of multiple sclerosis changing? Neuroepidemiology 36: 148-149.
3. Koutsouraki E, Costa V, Baloyannis S, (2010) Epidemiology of multiple sclerosis in Europe: a review. Int Rev Psychiatry 22: 2-13.
4. Hirst C, Ingram G, Pickersgill T, Swingler R, Compston DA, et al. (2009) Increasing prevalence and incidence of multiple sclerosis in South East Wales. J Neurol Neurosurg Psychiatry 80: 386-391.
5. Lauer K, (2010) Environmental risk factors in multiple sclerosis. Expert Rev Neurother 10: 421-440.
6. Giovannoni G, Ebers G, (2007) Multiple sclerosis: the environment and causation. Curr Opin Neurol 20: 261-268.
7. Ebers GC, (2008) Environmental factors and multiple sclerosis. Lancet Neurol 7: 268-277.
8. Wingerchuk DM, (2011) Environmental factors in multiple sclerosis: Epstein-Barr virus, vitamin D, and cigarette smoking. Mt Sinai J Med 78: 221-230.
9. Zhao H, Xia B, Fan C, Zhao P, Shen S, (2012) Human health risk from soil heavy metal contamination under different land uses near Dabaoshan Mine, Southern China. Sci Total Environ 417-418: 45-54.
10. Chiang CT, Lian Ie B, Su CC, Tsai KY, Lin YP, et al. (2010) Spatiotemporal trends in oral cancer mortality and potential risks associated with heavy metal content in Taiwan soil. Int J Environ Res Public Health 7: 3916-3928.
11. Boffetta P, Nyberg F, (2003) Contribution of environmental factors to cancer risk. Br Med Bull 68: 71-94.
12. Aelion CM, Davis HT, McDermott S, Lawson AB, (2009) Soil metal concentrations and toxicity: associations with distances to industrial facilities and implications for human health. Sci Total Environ 407: 2216-2223.
13. Johnson S, (2000) The possible role of gradual accumulation of copper, cadmium, lead and iron and gradual depletion of zinc, magnesium, selenium, vitamins B2, B6, D, and E and essential fatty acids in multiple sclerosis. Med Hypotheses 55: 239-241.
14. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13: 227-231.
15. Hwang BF, Jaakkola JJ, (2008) Ozone and other air pollutants and the risk of oral clefts. Environ Health Perspect 116: 1411-1415.
16. Medade MS, Earickson RJ (2000) Medical geography: New York:Guilford.
17. Poskanzer DC, Walker AM, Prenney LB, Sheridan JL, (1981) The etiology of multiple sclerosis: temporal-spatial clustering indicating two environmental exposures before onset. Neurology 31: 708-713.
18. Conradi S, Malzahn U, Schroter F, Paul F, Quill S, et al. (2011) Environmental factors in early childhood are associated with multiple sclerosis: a case-control study. BMC Neurol 11: 123.
19. Fisher AA, Le Couteur DG, (2000) Lead poisoning from complementary and alternative medicine in multiple sclerosis. J Neurol Neurosurg Psychiatry 69: 687-689.
20. Turabelidze G, Schootman M, Zhu BP, Malone JL, Horowitz S, et al. (2008) Multiple sclerosis prevalence and possible lead exposure. J Neurol Sci 269: 158-162.
21. Robertson DA, Low-Beer TS, (1983) Long term consequences of arsenical treatment for multiple sclerosis. Br Med J (Clin Res Ed) 286: 605-606.
22. Ammatuna E, Montefusco E, Pacilli M, Divona M, Ardiri D, et al. (2009) Use of arsenic trioxide in secondary acute promyelocytic leukemia developing after treatment of multiple sclerosis with mitoxantrone. Leuk Lymphoma 50: 1217-1218.
23. Klein D, Wan YJ, Kamyab S, Okuda H, Sokol RZ, (1994) Effects of toxic levels of lead on gene regulation in the male axis: increase in messenger ribonucleic acids and intracellular stores of gonadotrophs within the central nervous system. Biol Reprod 50: 802-811.
24. Lindberg AL, Kumar R, Goessler W, Thirumaran R, Gurzau E, et al. (2007) Metabolism of low-dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms. Environ Health Perspect 115: 1081-1086.